NCT05511558View on ClinicalTrials.gov

A Study of the Absorption, Metabolism, and Excretion of [14C]-Fosgonimeton (ATH-1017)

PHASE1CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

July 13, 2022

Primary Completion Date

October 18, 2022

Study Completion Date

October 26, 2022

Conditions

Healthy Volunteers

Interventions

DRUG

[14C]-Fosgonimeton

Carbon-14 Radiolabeled Fosgonimeton

Trial Locations (1)

53704

Labcorp Clinical Research Unit, Madison

Sponsors

Lead Sponsor

Collaborators (1)

Alturas Analytics, Inc.

All Listed Sponsors

collaborator

Labcorp Corporation of America Holdings, Inc

INDUSTRY

collaborator

Alturas Analytics, Inc.

UNKNOWN

lead

Athira Pharma

INDUSTRY

NCT05511558 - A Study of the Absorption, Metabolism, and Excretion of [14C]-Fosgonimeton (ATH-1017) | Biotech Hunter | Biotech Hunter